MyJournals Home  

RSS FeedsImmunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer (Prostate Cancer and Prostatic Diseases)

 
 

25 february 2020 00:00:49

 
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer (Prostate Cancer and Prostatic Diseases)
 




 
164 viewsCategory: Oncology, Pathology
 
Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer (Prostate Cancer and Prostatic Diseases)
Androgen receptor variant-driven prostate cancer II: advances in clinical investigation (Prostate Cancer and Prostatic Diseases)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten